• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytokinetics (NQ: CYTK )

    52.60 -0.20 (-0.38%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 990,817
    Open 52.44
    Bid (Size) 52.59 (2)
    Ask (Size) 52.65 (14)
    Prev. Close 52.80
    Today's Range 51.62 - 52.78
    52wk Range 25.98 - 110.25
    Shares Outstanding 95,640,600
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Analysts Think There's Still Time to Get in on Edgewise, Up 332%
    Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run? 
    Via MarketBeat
    Edgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares Dip
    Edgewise Therapeutics is trying to edge into a market already owned by Bristol Myers Squibb, just behind Cytokinetics. 
    Via Investor's Business Daily

    Performance

    YTD
    -37.47%
    -37.47%
    1 Month
    -3.59%
    -3.59%
    3 Month
    -3.84%
    -3.84%
    6 Month
    -27.96%
    -27.96%
    1 Year
    +88.60%
    +88.60%

    More News

    Read More
    Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study
    Via Benzinga
    CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Cytokinetics' Wild Ride: Can Investors Forgive The Royalty Pharma Deal?
    Via Investor's Business Daily
    Peering Into Cytokinetics's Recent Short Interest
    Via Benzinga
    7 Biotech Stocks to Boost Your Portfolio to Peak Health
    Via InvestorPlace
    June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
    Via InvestorPlace
    Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
    Via Benzinga
    Topics Earnings Stocks
    Exposures Financial US Equities
    Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
    Via Benzinga
    8 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Stocks Mixed Amid Flood Of Economic Data
    Via Talk Markets
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Gold Falls Sharply; US Composite PMI Surges In May
    Via Benzinga
    Why Cytokinetics (CYTK) Shares Are Falling
    Via Benzinga
    Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    VF Corp Posts Weak Q4 Results, Joins NetEase, Cytokinetics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
    From Royalty Pharma plc; Cytokinetics
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    Via Investor's Business Daily
    CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.